China's Leader in Experimental Animal Quality Testing
Suzhou Xishan Biotechnology Co., Ltd. is the first third-party service organization in Asia dedicated exclusively to laboratory animal quality testing. The company integrates technology R&D, diagnostic reagent production, testing services, and collaborative research, offering a one-stop platform for laboratory animal health monitoring and disease diagnosis. Equipped with internationally advanced testing equipment and backed by a team of seasoned experts, we ensure the accuracy and reliability of all test results. We also operate an independent Class D-level cleanroom facility specifically designed for the production of in vitro diagnostic reagents, developing and manufacturing specialized laboratory animal diagnostic kits that fully replace imported products. Our R&D center supports scientific research and accelerates the translation of innovations into practical applications, providing comprehensive virus, bacterial, and immunology-related testing services essential for new drug development, along with customized technical solutions and outsourced research services tailored to specific client needs.
Industry Experience
Countries and Regions
Customer
Test sample
Corporate Culture
Philosophy
Pioneering excellence in health monitoring for laboratory animals
Mission
Creating value for customers, opportunities for employees, and benefits for society.
Vision
Delivering comprehensive and reliable products and services across the industry.
Mission
Creating value for customers, opportunities for employees, and benefits for society.
Vision
Providing customers with comprehensive, high-quality products and services in the same industry.
Quality Policy
Fairness, science, accuracy, efficiency
Core Values
Honesty
Integrity
Dedication
Innovation
Development Journey
2024
Achieved GMP certification for veterinary drugs.
2023
Recognized as a national-level "Little Giant" enterprise for specialized, niche, and innovative companies.
2022
Registered with a Biosafety Level 2 Laboratory (BSL2).
2021
Awarded the title of High-Tech Enterprise.
Achieved ISO9001 Quality Management System Certification.
2020
Pioneered mIGRA technology for experimental monkey testing.
2018
Launched genetic testing for laboratory animals and established a clinical testing center.
2017
Introduced self-developed rodent reagents to the market.
2015
Completed a standalone testing building.
2014
Certified by the Metrology Accreditation (CMA) of Jiangsu Provincial Bureau of Quality and Technical Supervision.
2012
Began pathogen detection in rodent experimental animals.
2011
Accredited by the China National Accreditation Service for Conformity Assessment (CNAS).
2010
Established an independent reagent workshop and R&D center.
2007
Entered Suzhou BioBay Industrial Park to launch health monitoring for experimental monkeys.
2005
Founded on Xishan Island, Suzhou, starting virus detection experiments in monkeys.